Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)

Market Cap	7.42B -7.3%
Revenue (ttm)	6.85B -14.1%
Net Income	374.58M +8.1%
EPS	0.27 +9.4%
Shares Out	1.43B
PE Ratio	19.61
Forward PE	n/a
Dividend	0.10 (1.94%)
Ex-Dividend Date	Jun 23, 2025

Volume	13,068,081
Average Volume	16,762,619
Open	5.32
Previous Close	5.15
Day's Range	5.14 - 5.32
52-Week Range	4.62 - 6.68
Beta	0.24
RSI	40.10
Earnings Date	Apr 3, 2026

About SHE:000597

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biopharmaceuticals, and other businesses in China. It offers vitamin products,such as vitamin C, vitamin B1, vitamin B6, and L-carnitine series; anti-infection products, such as fosfomycin series, azithromycin series, amantadine series, berberine hydrochloride, chloramphenicol, and other products; and reproductive system and sex hormone products comprising carboprost suppositories, carboprost tromethami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1946
• Employees: 5,964
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000597

Financial Performance

In 2024, SHE:000597's revenue was 7.50 billion, a decrease of -8.98% compared to the previous year's 8.24 billion. Earnings were 409.85 million, an increase of 14.34%.